posted July 23, 2010 07:55 AM         

There’s been a cancer cure since 1992; scores of scientists have worked on it and published their results, but the clear leader is Dr. Nobuto Yamamoto in Philadelphia USA, who’s wholly cured 24 people of cancer by using their own immune systems, with no side effects.

How does it work?

In a healthy person macrophages in our bloodstream scour our bodies and kill maligancies; they get the message to go on the attack from Gc MAF, which is converted from Gc Protein.

But malignant cells like cancer send out an enzyme called Nagalase that stops conversion of Gc protein to Gc MAF (Macrophage Activating Factor); so the macrophages never get the message to go into action – in this way cancer suppresses the immune system, and cancer cells grow unchecked.

The cure is to extract Gc Protein from blood; modify it outside the body to become the missing Gc-MAF, and inject it once a week for 22 weeks.

The problem for pharmeceutical companies is the only product they can sell here is blood, and they don’t own that (yet. Codex Alimentaris may give them that control.) So no big organisations are interested. It seems the cure is so effective it would kill off the £15 billion a year cancer research conglomerates, and replace it with tiny cottage industries. All those directorships would be gone.

They are looking at writing off the £300 billion spent on Cancer research (99% spent in the wrong direction) over the last 40 years, with no product at the end of it. So Gc MAF is ignored by the big guys, whose interest seems limited to waiting for the EU’s Codex Alimentaris, or finding a way to patent Gc-MAF or its production. At the moment patenting doesn’t look possible.

Little organisations can’t do anything because they are ruthlessly controlled by regulations; enforced by the appalling FDA in the USA, which licenses damaging billion dollar products from big pharma, but blocks inexpensive cures for ten years; and by government in England, that has innovating doctors, biochemists and oncologists scared stiff of being struck off. The medical profession is terrified even to do do trials. Codex Alimentaris will seal the governments grip in every direction. If I may precis from cancerwife.com:

“In the USA, the FDA has now made it virtually IMPOSSIBLE for any non-patentable drug/procedure to be approved, because they insist on multiple phases of clinical trials. It takes hundreds of millions of dollars (seriously) to accomplish this. This limits approval to drugs/procedures patented by large drug corporations. Therefore, in it’s attempt to regulate, the FDA has essentially corrupted scientific medicine.”

The gcmaf cure has been published by Reuters newsagency, and its on hundreds of websites. (Its like the Lisbon Treaty: the Queen signed it, but the media does not explain it means the democratic nation of Britain ceased to exist in 2009, and we are now ruled by the EU’s three unelected politburos.)

I’ve taken some gcmaf to ensure its harmless. But it really kicked my immune system into gear; it felt as if I was fighting off flu for a day, but there was nothing wrong with me.

If you know someone who has done their own research on Gc MAF and is determined to take it, give them my phone number and I’ll put them in touch with people working undergound this side of the Atlantic.

posted August 28, 2010 06:49 PM         

quote:

---

Trails closed at the end of July 2010.

Fourteen weeks in, what had we learned?

Dr Yamamoto carefully selected his trials: he took only fit people with in the early stages of cancer, and claimed 95-100% success. He did not demonstrate success with tumour mass, ie he did not attempt to cure people with large tumours.

Our trials were quite different: most people are over 50, some over 70, with long term and advanced cancers, with significant tumour mass.

We appear to have had stunning results in 20 percent of cases. But GcMAF does not work for everyone. It seems people fall into three categories: high, moderate and non responders to GcMAF. Tumours can shrink in volume by 50% by the 8th shot; if so you are a high responder. But there are some advanced cases for moderate responders for whom GcMAF will not work on its own: it needs more help.

We are investigating whether our results were because of genetic make up of the different members of our trial group, some of whom react brilliantly, some moderately, some not at all. Any help here much appreciated.

We have probably proved GcMAF can work for people up to age 67, with terminal stage 4 cancer, and can completely destroy large tumour mass in people of certain genotypes. See "Patients on GcMAF" on the left.

We have no success with bedridden or inactive people. Those patients who are in excellent remission after 8 weeks all take exercise, at least a 40 minute brisk walk each day. It seems the immune system doesn't wake up without exercise.

We seem to have better results than the group on "Yamamoto" GcMAF made in Israel, but that may be because of the genetic make up of their group, not because of their GcMAF.

We have no success at all so far with aids; that again may be the genetic make up of our very small sample.

So we are now trying to find out how to make GcMAF work in serious cases for a wider group of people, and again, any help much appreciated.

If we stick our necks out, it appears:

1. GcMAF works for most people in the early stages of cancer, as shown by Dr. Yamamoto.

2. In people with genotypes similar to that found in Viking / Scandanavian / Saxon peoples, GcMAF, from whatever source, appears to work for most (not all) people with advanced, long term stage 4 cancers and will destroy large tumour mass, providing they take significant exercise. Outside that genotype success seemed to be under 10 percent.

And no, do not rely on that yet.

Many thanks to all who took part, and for the good friends we have made.

---